BiVictriX Therapeutics (BVX) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Sep 2024 07:30 AM
EQS
BiVictriX Therapeutics plc Shares now trading...
11 Sep 2024 07:00 AM
RNS
Cancellation - BiVictriX Therapeutics plc
10 Sep 2024 11:04 AM
RNS
Holding(s) in Company
10 Sep 2024 07:00 AM
RNS
Last Day of Dealings
09 Sep 2024 07:00 AM
RNS
Positive In Vivo Data from BVX002 Programme
02 Sep 2024 05:04 PM
RNS
Holding(s) in Company
02 Sep 2024 08:50 AM
RNS
Director Dealing
29 Aug 2024 05:05 PM
RNS
Result of General Meeting
28 Aug 2024 10:14 AM
RNS
Holding(s) in Company
28 Aug 2024 10:12 AM
RNS
Holding(s) in Company
19 Aug 2024 07:00 AM
RNS
TR-1: Notification of major holdings
13 Aug 2024 07:00 AM
RNS
Grant of Options
12 Aug 2024 07:00 AM
RNS
Proposed Voluntary Delisting
01 Aug 2024 07:00 AM
RNS
Interim Results
24 Jul 2024 05:00 PM
RNS
Result of Annual General Meeting
26 Jun 2024 07:00 AM
RNS
Publication of 2023 Annual Report & Notice of AGM
13 Jun 2024 07:00 AM
RNS
Compelling Safety Profile of BVX001
06 Jun 2024 07:00 AM
RNS
Innovate UK Grant Award to Accelerate ADC Pipeline
31 May 2024 08:44 AM
RNS
BiVictriX – Full Year Results 2023
17 Apr 2024 07:00 AM
RNS
Orphan Drug Designation & FDA INTERACT Meeting
28 Mar 2024 07:00 AM
RNS
Grant of Options – PDMR/Director Dealings
04 Jan 2024 12:30 PM
RNS
Holding(s) in Company
04 Jan 2024 12:30 PM
RNS
Holding(s) in Company
04 Jan 2024 07:00 AM
RNS
BiVictriX Hosts Inaugural Roundtable Discussion
05 Dec 2023 11:08 AM
RNS
Board Change
30 Nov 2023 07:00 AM
RNS
Pipeline update on BVX002
22 Nov 2023 05:14 PM
RNS
Holding(s) in Company
15 Nov 2023 07:00 AM
RNS
Patent Granted in Japan
12 Oct 2023 07:00 AM
RNS
Extended Survival Rates Reported with BVX001
03 Oct 2023 07:00 AM
RNS
Appointment of Adrian Howd as CFO and CBO
19 Sep 2023 07:00 AM
RNS
Interim Results
31 Aug 2023 07:00 AM
RNS
Total Voting Rights
23 Aug 2023 07:00 AM
RNS
US Patent Granted
17 Aug 2023 07:00 AM
RNS
Holding(s) in Company
16 Aug 2023 06:00 PM
RNS
Holding(s) in Company
11 Aug 2023 04:17 PM
RNS
Holding(s) in Company
08 Aug 2023 05:18 PM
RNS
Result of General Meeting
19 Jul 2023 06:16 PM
RNS
Result of Conditional Fundraise
19 Jul 2023 12:31 PM
RNS
Proposed Fundraise in excess of £2 million
19 Jul 2023 12:31 PM
RNS
Proposed Fundraise in excess of £2 million
17 Jul 2023 07:00 AM
RNS
Positive final data in preclinical efficacy study
19 Jun 2023 07:00 AM
RNS
Positive interim data
06 Jun 2023 07:00 AM
RNS
BiVictriX nominates clinical candidate for BVX001
04 May 2023 04:36 PM
RNS
Result of Annual General Meeting
31 Mar 2023 07:00 AM
RNS
Publication of Annual Report and Notice of AGM
30 Mar 2023 07:00 AM
RNS
BiVictriX Full Year Results
01 Mar 2023 07:01 AM
RNS
Appointment of Alex Hughes as CFO
31 Jan 2023 07:08 AM
RNS
BiVictriX reports positive BVX001 preclinical data
24 Jan 2023 04:21 PM
RNS
Holding(s) in Company
19 Jan 2023 11:00 AM
RNS
Holding(s) in Company
UK 100